Company / Revenue per Share
Incyte Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$26.58
FY2025
5-year range
$13.61 / $26.58
FY2021-FY2025
Trend
+40.6%
vs FY2024
Sector context
#19 of 154
Health Care
What the data says
Incyte's revenue per share of $26.58 is higher than 88% of companies in the Health Care sector (FY2025). Revenue per Share has increased for 6 consecutive years, from $7.20 in FY2019 to $26.58 in FY2025.
Based on SEC 10-K filings.
26.58 in FY2025 with a 5-year CAGR of +25.0%. Top quartile in the Health Care sector.
Improved from $16.59 to $26.58 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +20.1%
- 5-Year CAGR
- +25.0%
- 10-Year CAGR
- -
Sector benchmark
Top 12% in Health CareTop 12% of 154This company $26.58 Sector average $15.09
▼
+76.1% above sector average
Key checks
Key Insights
- Incyte's revenue per share has grown for 6 consecutive years.
- In FY2025, revenue per share increased 40.6% year-over-year.
- Ranks #19 out of 154 companies in the Health Care sector.
- Lowest revenue per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 3.01 (safe zone, above 2.9 threshold)
- Strong profit margin: 24.7%
- Strong return on equity: 25.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $26.58 | +40.6% |
| FY2024 | $18.91 | +14.0% |
| FY2023 | $16.59 | +8.1% |
| FY2022 | $15.35 | +12.9% |
| FY2021 | $13.61 | +56.3% |
| FY2020 | $8.71 | +20.9% |
| FY2019 | $7.20 | -19.1% |
| FY2018 | $8.91 | +9.5% |
| FY2017 | $8.13 | +37.3% |
| FY2016 | $5.92 | +34.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026